|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01406 CLARITY MEDICAL
Nominal 
0.385 0.000 (0.000%) | 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | |
| Turnover | 87,201 | -14.181% | 190,933 | 213,847 | 225,237 | 222,381 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (7,297) | -- | (30,049) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (17,669) | -24.151% | (81,896) | (2,917) | 19,046 | 43,816 | |
| Taxation | (900) | -- | 6,103 | (274) | (5,555) | (8,047) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (18,569) | -7.243% | (75,793) | (3,191) | 13,491 | 35,769 | |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | |
| Net Finance Costs / (Income) | (1,820) | 2.305% | (4,200) | (2,327) | 730 | 900 |
| Depreciation & Amortisation | 11,172 | -34.410% | 37,383 | 24,906 | 22,093 | 26,718 |
| Directors' Emoluments | -- | -- | 7,506 | 6,483 | 2,510 | 1,348 |
| 2024/09 - Interim | %Chg (Compare to Interim) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/09 - Interim | %Chg (Compare to Interim) | 2024/03 | 2023/03 | 2022/03 | 2021/03 | |
| EPS (cts) | -3.500 | -7.895% | -14.400 | -0.600 | 3.500 | 9.500 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.030) | 0.031 | 0.071 | 0.190 |
| NBV per share ($) | 0.329 | -- | 0.359 | 0.491 | 0.501 | -- |
| Remarks: | Real time quote last updated: 20/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -18,569,000 |
| %Change | -7.243% |
| EPS / (LPS) | HKD -0.035 |
| NBV Per Share ($) | HKD 0.329 |